Researchers from the University of Missouri found that a natural compound, Luteolin, found in herbs such as thyme and parsley and vegetables such as celery and broccoli, can reduce the risk of developing metastasis originating from triple-negative breast cancer in women.
The findings indicate that Luteolin, a naturally occurring, non-toxic plant compound that has been proven effective against several types of cancer.
“Triple-negative breast cancers are cancer cells that lack three receptors targeted by current chemotherapy regimens. Because of this lack of receptors, common cancer drugs can’t ‘find’ the cells, and doctors must treat the cancer with extremely aggressive and highly toxic treatment strategies,” said Salman Hyder from the College of Veterinary Medicine and the Dalton Cardiovascular Research Center.
“Women with this type of breast cancer also frequently develop metastatic lesions that originate from drug-resistant cells. Therefore, safer therapeutic therapies that are more effective are being sought for this deadly type of cancer in women,” Hyder added.
The team tested Luteolin to determine if it could suppress metastasis, using human triple-negative breast cancer cells grown in mice.
In the first series of tests, they found that Luteolin inhibited the metastasis of triple-negative cancer in the lungs of affected mice.
“Mice exposed to human triple-negative breast cancer cells experienced significantly reduced metastastic growth in their lungs after being treated with Luteolin,” Hyder stated.
“In almost every case, the mice also saw no weight loss, which means luteolin has no toxic effects; this plant compound is both safe and effective,” Hyder explained.
They found that Luteolin inhibits that migration and can also kill cancer cells.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022
